Objective: To investigate and compare the effectiveness of various treatment protocols for the treatment of women with idiopathic detrusor overactivity.
Design: Prospective, randomized controlled trial.
Setting: Departments of Physiotherapy and Rehabilitation and Obstetrics and Gynaecology, Hacettepe University.
Subjects: Forty-six subjects were randomized to three groups.
Interventions: The first group received only pharmacotherapy, the second group received only physiotherapy and in the third group pharmacotherapy was combined with physiotherapy (combined therapy group).
Main measures: All patients were evaluated at the beginning and at the end of treatment. Assessment parameters were maximum cystometric capacity, electromyographic activity of pelvic floor muscles, voiding diary parameters, the amount of urine leakage and the quality of life score.
Results: The maximum cystometric capacity and the electromyographic activity of pelvic floor muscles increased significantly and the number of voids/day and incontinence episodes/day, and the amount of urine leakage reduced significantly (P < 0.05) in both physiotherapy and combined therapy groups while there was no significant difference in the pharmacotherapy group. After treatment, the number of voids/day increased by 0.3 ± 3.4 in the pharmacotherapy group (P > 0.05) and decreased by 5.1 ± 5.5 and 4.7 ± 5.6 in the physiotherapy and combined therapy groups, respectively (P < 0.05). Statistically significant improvements were observed in all groups according to the number of voids/night and the quality of life scores at the end of the treatment.
Conclusion: The physiotherapy protocol we introduced in the present study with or without anticholinergic therapy has a substantial positive impact on the treatment of female patients with idiopathic detrusor overactivity.
Get full access to this article
View all access options for this article.
References
1.
AbramsPCardozoLFallM. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–78.
2.
JabsCFIStantonSL. Urge incontinence and detrusor instability. Int Urogynecol J 2002; 12: 58–68.
3.
BulmerPAbramsP. The unstable detrusor. Urol Int 2004; 72: 1–12.
4.
HerbisonPHay-SmithJEllisGMooreKH. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003; 326: 841–44.
5.
MorrisARO’SullivanRDunkleyPMooreKH. Extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial. Eur Urol 2007; 52: 876–81.
6.
DuckettJRTamilselviA. Effect of tension-free vaginal tape in women with a urodynamic diagnosis of idiopathic detrusor overactivity and stress incontinence. BJOG 2006; 113: 30–3.
7.
CardozoLChappleCRToozs-HobsonP. Efficacy of trospium chloride in patients with detrusor instability: a placebo-controlled, randomized, double-blind, multicentre clinical trial. BJU Int 2000; 85: 659–64.
8.
HalaskaMRalphGWiedemannA. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol 2003; 20: 392–99.
9.
YarkerYEGoaKLFittonA. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its theurapeutic use in detrusor instability. Drugs Aging 1995; 6: 243–62.
10.
YalçınOTHassaHSaraçI. Short-term intravaginal maximal electrical stimulation for refractive detrusor insatability. Int J Gynaecol Obstet 2002; 79: 241–44.
11.
FrewenW. Role of bladder training in the treatment of the unstable bladder in the female. Urol Clin N Am 1979; 6: 273–79.
12.
BerghmansLCMHendriksHJMDe BieRAvan Waalwijk van DoornESBøKvan KerrebroeckPE. Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials. BJU Int 2000; 85: 254–63.
13.
Alhasso AA, McKinlay J, Patrick K, Stewart L. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006; 4: CD003193.
14.
ArrudaRMCastroRSartoriMGirãoMJ. Comparison between oxybutynin, functional electrical stimulation and pelvic floor training for treatment of detrusor overactivity in women: e review. Curr Opin Obstet Gynecol 2009; 21: 412–14.
15.
ChancellorMBHasenauDL. Is behavioral therapy plus antimuscarinic better than drug alone to treat overactive bladder?Rev Urol 2008; 10: 306–8.
16.
ShamliyanTAKaneRLWymanJWiltTJ. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 2008; 148: 459–73.
17.
BøKSherburnM. Evaluation of female pelvic-floor muscle function and strength. Phys Ther 2005; 85: 269–82.
18.
PoldenMMantleJ. Continence and incontinence. In: PoldenMMantleJ. (eds) Physiotherapy in obstetrics and gynaecology . Oxford: Butterworth-Heinemann, 1994, 335–87.
19.
JørgensenLLoseGAndersJ. One hour-pad weighing test for objective assessment of female urinary incontinence. Obstet Gynecol 1987; 69: 39–43.
20.
WagnerTHPatricDLBavendamTGMartinMLBueschingDP. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996; 47: 67–72.
21.
KaranAAksacBAyyıldızHIsıkogluM. Quality of life and its relation with objective assessment parameters in urinary incontinent patients. Turk J Geriatr 2000; 3: 102–6.
22.
AkbayrakTYükselIDemirtürkF. The short-term effects of physical therapy in different intensities of urodynamic stress incontinence. Gynecol Obstet Invest 2005; 59: 43–8.
23.
DemirtürkFAkbayrakTKarakayaIC. Interferential current versus biofeedback results in urinary stress incontinence. Swiss Med Wkly 2008; 138: 317–21.
24.
DumoulinCSeaborneDEDeGirardiCQSullivanSJ. Pelvic-floor rehabilitation, Part 1: Comparison of two surface electrode placements during stimulation of the pelvic-floor musculature in women who are continent using bipolar interferential currents. Phys Ther 1995; 75: 1067–74.
25.
MauroyBDevillersPDemetriouDAmetepeBBiserteJ. Treatment of bladder instability with interferential current. Report of 20 cases: preliminary results. Prog Urol 1992; 2: 664–70.
26.
ZimmernPLitmanHJMuellerENortonPGoodeP. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int 2009; 105: 1680–85.
27.
SampselleCM. Behavioral intervention for urinary incontinence for women: evidence for practice. J Midwifery Womens Health 2000; 45: 94–103.
28.
AlloussiSLavalKUEckertR. Trospium chloride (Spasmo-lyt®) in patients with motor urge syndrome (detrusor instability): double-blind, randomized, placebo-controlled study. J Clin Res 1998; 1: 439–51.
29.
MillardRJOldenburgBF. The symptomatic, urodynamic and psychodynamic results of bladder re-education programs. J Urol 1983; 130: 715–19.
30.
ArrudaRMCastroRASartoriMG. Clinical and urodynamic evaluation of women with detrusor instability before and after functional pelvic floor electrostimulation. Clin Exp Obstet Gynecol 2003; 30: 220–22.
31.
OzdedeliSKarapolatHAkkocY. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study. Clin Rehabil 2010; 24: 342–51.
32.
FreemanRMAdekanmiOA. Overactive bladder. Best Pract Res Clin Obstet Gynaecol 2005; 19: 829–41.
33.
BrownJSMcNaughtonKSWymanFJ. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology 2003; 61: 802–9.
ElgamasyANLewisVHassounaMEGhoniemGM. Effect of transvaginal stimulation in the treatment of detrusor instability. Urol Nurs 1996; 16: 127–30.
36.
NygaardIEKrederKJLepicMMFountainKARhombergAT. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. Am J Obstet Gynecol 1996; 174: 120–25.
37.
ZinnerNGittelmanMHarisRSussetJKanelosAAuerbachS. Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. J Urol 2004; 171: 2311–15.
38.
GrapeHHDederingAJonassonAF. Retest reliability of surface electromyography on the pelvic floor muscles. Neurourol Urodyn 2009; 28: 385–99.
39.
PeschersUMGingelmaierAJundtKLeibBDimpflT. Evaluation of pelvic floor muscle strength using four different techniques. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 27–30.
40.
TheofrastousJPWymanJFBumpRC. Effects of pelvic floor muscle training on strength and predictors of response in the treatment of urinary incontinence. Neurourol Urodyn 2002; 21: 486–90.
PrajsnerARadziszewskiP. Ambulatory diagnosis of urinary incontinence among women: the role of a one hour pad weigh test. Wiad Lek 1998; 51: 254–59.
43.
Oh-OkaH. Efficacy of interferential low frequency therapy for elderly wet overactive bladder patients. Indian J Urol 2008; 24: 178–81.
44.
GoldmanHBAmundsenCLMangelJ. Dorsal genital nerve stimulation for the treatment of overactive bladder symptoms. Neurourol Urodyn 2008; 27: 499–503.
45.
JefferySFynesMLeeFWangKWilliamsLMorleyR. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 2007; 100: 1302–6.
KhullarVChappleCGabrielZDooleyJA. The effects of antimuscarinics on health-related quality of life in overactive bladder: a systematic review and meta-analysis. Urology 2006; 68: 38–48.
48.
TodorovaAVonderheid-GuthBDimpfelW. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 2001; 41: 636–44.
49.
SongCParkJTHeoKOLeeKSChooMS. Effects of bladder training and/or tolterodine in female patients with overactive bladder syndrome: a prospective randomized study. J Korean Med Sci 2006; 21: 1060–63.
